Atlas Trials

Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice

Clinical trial NCT03290794 · COMPLETED

Trial details

NCT number
NCT03290794
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Wet Age-related Macular Degeneration
Start date
2019-02-14
Primary completion
2022-11-25
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.